SOURCE: Novo Nordisk A/S

October 13, 2008 09:23 ET

Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - October 13, 2008) - Novo Nordisk A/S - Share repurchase programme


On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008.

Since the announcement as of 6 October 2008, the following transactions have been made under the programme:

                  Number of shares     Average     Transaction
                                    purchase price value, DKK
Accumulated, last
announcement        1,938,500                     548,510,444
6 October 2008        125,000         279.9900     34,998,750
7 October 2008         50,000         269.1900     13,459,500
8 October 2008         50,000         262.8400     13,142,000
9 October 2008         60,000         260.2500     15,615,000
10 October 2008        50,000         250.4200     12,521,000
Accumulated under
the programme       2,273,500                     638,246,694

With the transactions stated above, Novo Nordisk owns a total of 23,486,460 treasury shares, corresponding to 3.7% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:


Mette Kruse Danielsen  Mads Veggerby Lausten
Tel: (+45) 4442 3883   Tel: (+45) 4443 7919
mkd@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com

In North America:
Sean Clements
Tel: (+1) 609 514 8316
secl@novonordisk.com

Company Announcement no 65 / 2008


This announcement is originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Copyright © Hugin AS 2008. All rights reserved.

Contact Information